AbCellera Biologics Inc. ABCL Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on trailing twelve months.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s return on invested capital?
- AbCellera Biologics Inc. (ABCL) reported return on invested capital of -22.5% in Q1 2026.
- How has AbCellera Biologics Inc.'s return on invested capital changed year-over-year?
- AbCellera Biologics Inc.'s return on invested capital increased by 31.5% year-over-year, from -32.9% to -22.5%.
- What is the long-term trend for AbCellera Biologics Inc.'s return on invested capital?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s return on invested capital has grown at a -13.5% compound annual growth rate (CAGR), from 34.5% to -22.3%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.